Onyx Pharmaceuticals to Present at Friedman Billings Ramsey Growth Investor Conference
May 25 2006 - 5:00PM
PR Newswire (US)
EMERYVILLE, Calif., May 25 /PRNewswire-FirstCall/ -- Onyx
Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will
present at the Friedman Billings Ramsey Growth Investor conference
on Thursday, June 1, at 11:15 a.m. Eastern Time. Interested parties
may access a live webcast of the presentation at:
http://www.wsw.com/webcast/fbr15/onxx/ It is recommended that
listeners log on 15 minutes early in order to register and download
any necessary software. For those unable to participate during the
live webcast, a recorded replay of the presentation will be
available within 24 hours of the completion of the presentation
through July 1, 2006. Onyx Pharmaceuticals is engaged in the
development of novel cancer therapies that target the molecular
basis of cancer. With its collaborators, the company is developing
small molecule drugs, including Nexavar(R) (sorafenib) tablets with
Bayer Pharmaceuticals Corporation. For more information about
Onyx's pipeline and activities, visit the company's website at
http://www.onyx-pharm.com/. NOTE: Nexavar(R) (sorafenib) tablets is
a registered trademark of Bayer Pharmaceuticals Corporation.
DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Alexandra Santos of
Onyx Pharmaceuticals, Inc., +1-510-597-6504 Web site:
http://www.onyx-pharm.com/
Copyright
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024